Headlines about Psychemedics Corporation (NASDAQ:PMD) have been trending somewhat positive this week, according to AlphaOne Sentiment Analysis. The research group, a subsidiary of Accern, rates the sentiment of press coverage by reviewing more than twenty million blog and news sources in real time. AlphaOne ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Psychemedics Corporation earned a news sentiment score of 0.24 on AlphaOne’s scale. AlphaOne also gave news headlines about the company an impact score of 0 out of 100, meaning that recent press coverage is extremely unlikely to have an effect on the company’s share price in the next several days.
Shares of Psychemedics Corporation (NASDAQ:PMD) opened at 21.78 on Friday. The firm has a market capitalization of $118.92 million, a P/E ratio of 14.62 and a beta of 1.02. The stock has a 50 day moving average of $20.92 and a 200-day moving average of $21.67. Psychemedics Corporation has a 52-week low of $13.00 and a 52-week high of $27.45.
Psychemedics Corporation (NASDAQ:PMD) last posted its earnings results on Tuesday, April 25th. The company reported $0.27 earnings per share (EPS) for the quarter. Psychemedics Corporation had a net margin of 19.29% and a return on equity of 56.76%. The business had revenue of $10.21 million for the quarter. Equities analysts expect that Psychemedics Corporation will post $0.93 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Thursday, May 18th. Shareholders of record on Monday, May 8th were paid a $0.15 dividend. This represents a $0.60 annualized dividend and a yield of 2.75%. The ex-dividend date of this dividend was Thursday, May 4th. Psychemedics Corporation’s dividend payout ratio is presently 40.27%.
COPYRIGHT VIOLATION WARNING: This article was posted by WKRB News and is owned by of WKRB News. If you are viewing this article on another website, it was illegally stolen and republished in violation of United States and international copyright & trademark law. The correct version of this article can be read at https://www.wkrb13.com/markets/2229995/psychemedics-corporation-pmd-earns-media-sentiment-score-of-0-24.html.
Psychemedics Corporation Company Profile
Psychemedics Corporation (Psychemedics) provides hair testing for drugs of abuse, utilizing a hair analysis method involving digestion of hair, enzyme immunoassay (EIA) technology and confirmation by mass spectrometry to analyze human hair to detect abused substances. The Company operates in drug testing services segment.
This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2229995/psychemedics-corporation-pmd-earns-media-sentiment-score-of-0-24.html
Receive News & Ratings for Psychemedics Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Psychemedics Corporation and related companies with MarketBeat.com's FREE daily email newsletter.